2/24
01:29 pm
acxp
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
2/16
08:10 am
acxp
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
2/16
08:01 am
acxp
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
Low
Report
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
2/2
08:33 am
acxp
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
Low
Report
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
2/2
08:00 am
acxp
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
Medium
Report
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
12/28
01:08 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
12/20
01:30 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S